Impact of ATG use on the outcome of patients with hematological malignancies undergoing reduced-intensity conditioning for allogeneic hematopoietic cell transplantation

被引：0

作者：

Greinix, H. ^{[1
]}

Beohou, E. ^{[1
]}

van der Werf, S. ^{[2
]}

Niederwieser, D. ^{[3
]}

Blaise, D. ^{[4
]}

Dreger, P. ^{[5
]}

Arnold, R. ^{[6
]}

Meijer, E. ^{[7
]}

Sengeloev, H. ^{[8
]}

Cornelissen, J. ^{[9
]}

Hallek, M. ^{[10
]}

Socie, G. ^{[11
]}

Chevallier, P. ^{[12
]}

Ganser, A. ^{[13
]}

Milpied, N. ^{[14
]}

Maertens, J. ^{[15
]}

Petersen, E. ^{[16
]}

Afanasyev, B. ^{[17
]}

Ehninger, G. ^{[18
]}

Fegueux, N. ^{[19
]}

Jindra, P. ^{[20
]}

Kroeger, N. ^{[21
]}

Montoto, S. ^{[22
]}

Nagler, A. ^{[23
]}

Duarte, R. ^{[24
]}

机构：

[1] EBMT Paris Study Off CEREST TC, Paris, France

[2] EBMT Study Coordinat Off, Leiden, Netherlands

[3] Univ Hosp Leipzig, Leipzig, Germany

[4] Inst Paoli Calmettes, Marseille, France

[5] Heidelberg Univ, Heidelberg, Germany

[6] Charite Univ Med Berlin, Berlin, Germany

[7] VU Univ Med Ctr Amsterdam, Amsterdam, Netherlands

[8] Rigshosp Copenhagen, Copenhagen, Denmark

[9] Erasmus MC Canc Inst Rotterdam, Rotterdam, Netherlands

[10] Univ Cologne, Cologne, Germany

[11] Hop St Louis Paris, Paris, France

[12] CHU Nantes, Nantes, France

[13] Hannover Med Sch, Hannover, Germany

[14] CHU Bordeaux, Bordeaux, France

[15] Univ Hosp Gasthuisberg, Leuven, Belgium

[16] Univ Med Ctr Utrecht, Utrecht, Netherlands

[17] First State Pavlov Med Univ St Petersburg, St Petersburg, Russia

[18] Univ Klinikum Dresden, Dresden, Germany

[19] CHU Lapeyronie Montpellier, Montpellier, France

[20] Charles Univ Hosp Pilsen, Plzen, Czech Republic

[21] Univ Hosp Eppendorf, Hamburg, Germany

[22] St Bartholomews & Royal London NHS Trust, London, England

[23] Chaim Sheba Med Ctr, Tel Hashomer, Israel

[24] Hosp Univ Puerta de Hierro Madrid, Madrid, Spain

来源：

BONE MARROW TRANSPLANTATION | 2017年 / 52卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O084

引用

页码：S61 / S61

页数：1

共 50 条

[1] Impact of ATG Dose on the Outcome of Patients Undergoing Reduced Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
Cornillon, Jerome
Balsat, Marie
Cabrespine, Aurelie
Tavernier-Tardy, Emmanuelle
Hermet, Eric
Mulliez, Aurelien
Augeul-Meunier, Karine
Guyotat, Denis
Bay, Jacques-Olivier
ACTA HAEMATOLOGICA, 2016, 136 (04) : 193 - 200
[2] Impact of Hyperferritinemia on the Outcome of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies
Barba, Pere
Valcarcel, David
Antonio Perez-Simon, Jose
Fernandez-Aviles, Francesc
Luis Pinana, Jose
Martino, Rodrigo
Lopez-Anglada, Lucia
Rovira, Montserrat
Garcia-Cadenas, Irene
Novelli, Silvana
Carreras, Enric
Lopez Corral, Lucia
Sierra, Jorge
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (04) : 597 - 601
[3] Better Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Reduced-Intensity Conditioning in Elderly Patients with Hematological Malignancies
Zhao, Yongqiang
Song, Yanzhi
Yang, Fan
Li, Feifei
Yang, Dongfang
Wu, Tong
BLOOD, 2021, 138
[4] Reduced-Intensity Conditioning in Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Historical Perspective
Cremer, Birgit
Sandmaier, Brenda M.
Bethge, Wolfgang
Lange, Thoralf
Goede, Valentin
Holtick, Udo
Hallek, Michael
Huebel, Kai
ONKOLOGIE, 2011, 34 (12): : 710 - 715
[5] Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies
Valcárcel, D
Martino, R
Sureda, A
Canals, C
Altés, A
Briones, J
Sanz, MA
Parody, R
Constans, M
Villela, SL
Brunet, S
Sierra, J
EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (02) : 144 - 151
[6] Excellent outcome of reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with Sezary Syndrome
Onida, F.
Saporiti, G.
Vincenti, D.
Annaloro, C.
Tagliaferri, E.
Motta, B.
Violetti, S. Alberti
Berti, E.
Cortelezzi, A.
BONE MARROW TRANSPLANTATION, 2015, 50 : S281 - S282
[7] The role of allogeneic stem cell transplantation with reduced-intensity conditioning in patients with chemoresistant malignancies
Prats, C.
Espigado, I.
Falantes, J.
Marquez, F.
Fernandez, I.
Parody, R.
Carmona, M.
Blas, J.
BONE MARROW TRANSPLANTATION, 2007, 39 : S299 - S300
[8] Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation
Marsh, Rebecca A.
Vaughn, Gretchen
Kim, Mi-Ok
Li, Dandan
Jodele, Sonata
Joshi, Sarita
Mehta, Parinda A.
Davies, Stella M.
Jordan, Michael B.
Bleesing, Jack J.
Filipovich, Alexandra H.
BLOOD, 2010, 116 (26) : 5824 - 5831
[9] Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies
Dominik Schneidawind
Birgit Federmann
Corina Buechele
Andrea Helwig
Jörg Schmohl
Wichard Vogel
Christoph Faul
Lothar Kanz
Wolfgang A. Bethge
Annals of Hematology, 2016, 95 : 115 - 124
[10] Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies
Schneidawind, Dominik
Federmann, Birgit
Buechele, Corina
Helwig, Andrea
Schmohl, Joerg
Vogel, Wichard
Faul, Christoph
Kanz, Lothar
Bethge, Wolfgang A.
ANNALS OF HEMATOLOGY, 2016, 95 (01) : 115 - 124

← 1 2 3 4 5 →